BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26920752)

  • 1. Impaired angiogenesis as a feature of digital ulcers in systemic sclerosis.
    Silva I; Almeida C; Teixeira A; Oliveira J; Vasconcelos C
    Clin Rheumatol; 2016 Jul; 35(7):1743-51. PubMed ID: 26920752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.
    Silva I; Teixeira A; Oliveira J; Almeida I; Almeida R; Águas A; Vasconcelos C
    Clin Rev Allergy Immunol; 2015 Oct; 49(2):240-52. PubMed ID: 26142066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of vascular disease biomarkers for digital ulcers in systemic sclerosis patients.
    Silva I; Teixeira A; Oliveira J; Almeida I; Almeida R; Vasconcelos C
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S127-30. PubMed ID: 26242908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
    Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M
    Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study.
    Reiseter S; Molberg Ø; Gunnarsson R; Lund MB; Aalokken TM; Aukrust P; Ueland T; Garen T; Brunborg C; Michelsen A; Abraityte A; Hoffmann-Vold AM
    Arthritis Res Ther; 2015 Aug; 17(1):231. PubMed ID: 26315510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis.
    Avouac J; Meune C; Ruiz B; Couraud PO; Uzan G; Boileau C; Kahan A; Chiocchia G; Allanore Y
    Ann Rheum Dis; 2012 Mar; 71(3):394-9. PubMed ID: 22085793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum level of endostatin and digital ulcers in systemic sclerosis patients.
    Gigante A; Margiotta D; Navarini L; Barbano B; Gasperini ML; D'Agostino C; Amoroso A; Afeltra A; Rosato E
    Int Wound J; 2018 Jun; 15(3):424-428. PubMed ID: 29600562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy.
    Gigante A; Navarini L; Margiotta D; Amoroso A; Barbano B; Cianci R; Afeltra A; Rosato E
    Microvasc Res; 2017 Nov; 114():41-45. PubMed ID: 28602918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction, microvascular damage and ischemic peripheral vasculopathy in systemic sclerosis.
    Silva I; Teixeira A; Oliveira J; Almeida R; Vasconcelos C
    Clin Hemorheol Microcirc; 2017; 66(2):117-130. PubMed ID: 28128745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Utility of Plasma Vascular Biomarkers in Systemic Sclerosis: A Prospective Longitudinal Analysis.
    Mecoli CA; Shah AA; Boin F; Wigley FM; Hummers LK
    Arthritis Rheumatol; 2020 Aug; 72(8):1341-1349. PubMed ID: 32200572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against Endothelin 1 Type A Receptor Are Strong Predictors of Digital Ulcers in Systemic Sclerosis.
    Avouac J; Riemekasten G; Meune C; Ruiz B; Kahan A; Allanore Y
    J Rheumatol; 2015 Oct; 42(10):1801-7. PubMed ID: 26233500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis--association with pulmonary involvement.
    Dziankowska-Bartkowiak B; Waszczykowska E; Dziankowska-Zaboroszczyk E; de Graft-Johnson JE; Zalewska A; Łuczyńska M; Nowak D
    Clin Exp Rheumatol; 2006; 24(5):508-13. PubMed ID: 17181918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function.
    Kawashiri SY; Nishino A; Igawa T; Takatani A; Shimizu T; Umeda M; Fukui S; Okada A; Suzuki T; Koga T; Iwamoto N; Ichinose K; Tamai M; Nakashima M; Mizokami A; Matsuoka N; Migita K; Ogawa F; Ikeda S; Maemura K; Nakamura H; Origuchi T; Maeda T; Kawakami A
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):102-108. PubMed ID: 29652651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital ulcers in systemic sclerosis: role of flow-mediated dilatation and capillaroscopy as risk assessment tools.
    Silva I; Loureiro T; Teixeira A; Almeida I; Mansilha A; Vasconcelos C; Almeida R
    Eur J Dermatol; 2015; 25(5):444-51. PubMed ID: 26693634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients.
    Silva I; Almeida J; Vasconcelos C
    Autoimmun Rev; 2015 Feb; 14(2):140-52. PubMed ID: 25449678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study.
    Cutolo M; Herrick AL; Distler O; Becker MO; Beltran E; Carpentier P; Ferri C; Inanç M; Vlachoyiannopoulos P; Chadha-Boreham H; Cottreel E; Pfister T; Rosenberg D; Torres JV; Smith V;
    Arthritis Rheumatol; 2016 Oct; 68(10):2527-39. PubMed ID: 27111549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different contributions of angiostatin and endostatin in angiogenesis impairment in systemic sclerosis: a cohort study.
    Almeida I; Oliveira Gomes A; Lima M; Silva I; Vasconcelos C
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):37-42. PubMed ID: 26885625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis.
    Gigante A; Margiotta D; Navarini L; Liberatori M; Barbano B; Tubani L; Afeltra A; Rosato E
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):24-27. PubMed ID: 29787366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin.
    Wipff J; Avouac J; Borderie D; Zerkak D; Lemarechal H; Kahan A; Boileau C; Allanore Y
    Rheumatology (Oxford); 2008 Jul; 47(7):972-5. PubMed ID: 18477643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.